Experience of pediatric liver disease at a university hospital in Western Saudi Arabia

References

1. 1.↵
   1. Abou-Taleb A,
   2. Ahmed A,
   3. El-Hennawy A.

   Pediatric chronic liver diseases: a clinicopathological study from a tertiary care center. Int J Pediatr 2019; 7: 9305.

   OpenUrl
2. 2.↵
   1. Anderson EL,
   2. Howe LD,
   3. Jones HE,
   4. Higgins JP,
   5. Lawlor DA,
   6. Fraser A.

   The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS One 2015; 10: e0140908.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Alamri AS,
   2. Alhomrani M,
   3. Alsanie WF,
   4. Alghamdi AJ,
   5. Alghamdi ZM,
   6. Al-Subaie AA, et al.

   Prevalence and predictors of non-alcoholic fatty liver disease in tertiary care hospital of Taif, Saudi Arabia: a retrospective study. Saudi J Biol Sci 2021; 28: 4921-4925.

   OpenUrlPubMed
4. 4.↵
   1. Meng Q,
   2. Li N,
   3. Yuan L,
   4. Gao X.

   Analysis of common causes of liver damage among children 12 years and younger in Weifang. J Int Med Res 2021; 49: 3000605211006661.

   OpenUrlPubMed
5. 5.↵
   1. Torbenson M,
   2. Washington K.

   Pathology of liver disease: advances in the last 50 years. Hum Pathol 2020; 95: 78-98.

   OpenUrlPubMed
6. 6.↵
   1. Chen F,
   2. Huang Y,
   3. Huang Z,
   4. Fang F,
   5. Zhou H,
   6. Shu S.

   The epidemiological characteristics of liver disease in hospitalized children: a 10-year single-center retrospective study. Front Pediatr 2024; 12: 1344714.

   OpenUrlPubMed
7. 7.↵
   1. Yu EL,
   2. Schwimmer JB.

   Epidemiology of pediatric nonalcoholic fatty liver disease. Clin Liver Dis (Hoboken) 2021; 17: 196-199.

   OpenUrlPubMed
8. 8.↵
   1. Martin M,
   2. Zou B,
   3. Hoang J,
   4. Jeong D,
   5. Bensen R,
   6. Nguyen MH.

   Racial and socioeconomic disparities in hospitalization of pediatrics with liver disease from 2005-2015. Dig Dis Sci 2021; 66: 2240-2249.

   OpenUrlPubMed
9. 9.↵
   1. Schwimmer JB,
   2. Deutsch R,
   3. Kahen T,
   4. Lavine JE,
   5. Stanley C,
   6. Behling C.

   Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-1393.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Mujlli G,
    2. Mahzari M,
    3. Alslamah I,
    4. Syed J,
    5. Omair A,
    6. Abulmeaty M, et al.

    Non-alcoholic fatty liver in children and adolescents in Saudi Arabia. Cureus 2023; 15: e46380.

    OpenUrlPubMed
11. 11.↵
    1. Chan M,
    2. Navarro VJ.

    Percutaneous liver biopsy. [Updated 2024; 2024 Aug 19]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553146/
12. 12.
    1. Piekarska A.

    Principles of the biopsy procedure. [Updated 2011; 2024 Aug 19]. Available from: https://www.intechopen.com/chapters/18766
13. 13.↵
    1. Saadah OI,
    2. Khayat A,
    3. Alsufyani HA,
    4. Bin-Taleb Y.

    Paediatric autoimmune liver diseases: a descriptive study of patients from Saudi Arabia. Arab J Gastroenterol 2021; 22: 146-150.

    OpenUrlPubMed
14. 14.↵
    1. Arya G,
    2. Balistreri WF.

    Pediatric liver disease in the United States: epidemiology and impact. J Gastroenterol Hepatol 2002; 17: 521-525.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Al-Hussaini A,
    2. Abanemai M,
    3. Alhebbi H,
    4. Saadah O,
    5. Bader R,
    6. Al Sarkhy A, et al.

    The epidemiology and outcome of biliary atresia: Saudi Arabian national study (2000-2018). Front Pediatr 2022; 10: 921948.

    OpenUrlPubMed